Current concepts in the pharmacotherapy of benign prostatic hyperplasia

Author： Khastgir Jay Arya Manit Shergill Iqbal S Kalsi Jas S Minhas Sux Mundy AnthonyR

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.12, 2002-12, pp. : 1727-1737

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current evidence supports the use of combination therapy in the management of benign prostatic hyperplasia

Drugs & Therapy Perspectives, Vol. 28, Iss. 12, 2012-12 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Benign prostatic hyperplasia: an insight into current investigational medical therapies

By Tiwari Atul Krishna N S Nanda Kamna Chugh Anita

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 11, 2005-11 ,pp. : 1359-1372

Informa Healthcare

Access to resources Recommend Favorite

Treatment options for benign prostatic hyperplasia

By Thurlow R.J.

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 225-246

Informa Healthcare

Access to resources Recommend Favorite

Dutasteride for the treatment of benign prostatic hyperplasia

By Wu Christopher Kapoor Anil

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. : 1399-1408

Informa Healthcare

Access to resources Recommend Favorite

Dutasteride/Tamsulosin: In Benign Prostatic Hyperplasia

By Keating Gillian M.

Drugs & Aging, Vol. 29, Iss. 5, 2012-05 ,pp. : 405-419

Adis International

Access to resources Recommend Favorite